Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Lewy Body Disease

• PET Imaging Evaluation of [11C]SY08
• Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
• Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones
• Comparing Antipsychotic Medications in LBD Over Time
• Immunohistochemical Study of Neurodegenerative Diseases
• MIBG in Aging and Neurologic Disorders
• Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
• A Phase I Study of GT300 in Healthy Subjects
• ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies
• A Study of E2027 in Participants With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) With or Without Amyloid Copathology
• Terazosin for Dementia With Lewy Bodies
• A Study of CST-103 Co-administered With CST-107 in Subjects With Neurodegenerative Disorders
• 18F-DOPA II - PET Imaging Optimization
• Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial
• Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia
• [18F]F-DOPA Imaging in Patients With Autonomic Failure
• NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)
• Monitoring Anti-Dementia Drugs by Serum Levels
• A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants
• Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
• Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies
• K0706 for Patients Diagnosed With Dementia With Lewy Bodies
• Trial of Parkinson's And Zoledronic Acid
• Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies
• A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies
• Longitudinal Imaging Biomarkers of Disease Progression in DLB
• A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
• Study To Evaluate the Efficacy, Safety and Tolerability of E2027 in Participants With Dementia With Lewy Bodies
• A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
• Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
• Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
• Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
• Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)
• Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies
• Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study
• Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
• Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).
• A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)
• Nilotinib in Cognitively Impaired Parkinson Disease Patients 001
• A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease
• A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
• A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase
• Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies
• "Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"
• Imaging of Brain Amyloid Plaques in the Aging Population
• Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
• Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies
• Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)
• Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)
• A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies
• A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)
• Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies
• Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia